Invention Grant
US09175060B2 PEG modified exendin or exendin analog and compositions and use thereof
有权
PEG修饰的毒蜥外泌肽或毒蜥外泌肽类似物及其组合物及其用途
- Patent Title: PEG modified exendin or exendin analog and compositions and use thereof
- Patent Title (中): PEG修饰的毒蜥外泌肽或毒蜥外泌肽类似物及其组合物及其用途
-
Application No.: US12514790Application Date: 2007-11-13
-
Publication No.: US09175060B2Publication Date: 2015-11-03
- Inventor: Wenchao Bao , Hongjing Xu , Gang Yu , Yajun Zuo
- Applicant: Wenchao Bao , Hongjing Xu , Gang Yu , Yajun Zuo
- Applicant Address: CN Shanghai
- Assignee: Shanghai Benemae Pharmaceutical Corporation
- Current Assignee: Shanghai Benemae Pharmaceutical Corporation
- Current Assignee Address: CN Shanghai
- Agency: Perkins Coie LLP
- Agent Yingli Wang
- Priority: CN200610118326 20061114; CN200710138718 20070723
- International Application: PCT/CN2007/003203 WO 20071113
- International Announcement: WO2008/058461 WO 20080522
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/575 ; A61K47/48 ; A61K38/00
Abstract:
Exendins or exendin analogs modified by one or more PEG derivatives that may be linked to one or more amino acids of the exendins or exendin analogs are provided. The PEG derivatives may have branched structure set forth in any one of formulas I-IV. Compositions including the PEG derivative modified exendin or exendin analog, methods of making or administering the modified exendin or exendin analog, and various uses thereof are also provided.
Public/Granted literature
- US20100240586A1 PEG MODIFIED EXENDIN OR EXENDIN ANALOG AND COMPOSITIONS AND USE THEREOF Public/Granted day:2010-09-23
Information query
IPC分类:
